NCT05586867 Study of Markers of Iron Metabolism and Their Relationship With Phosphocalcic and Hepatic Metabolism and Inflammation in Hemodialysis Patients
| NCT ID | NCT05586867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Iron Metabolism Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-12-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
From a scientific point of view and for publication purposes, it therefore seems important to study the metabolism of iron and in particular to define its conditions of absorption, metabolism, elimination and storage in the body at course of advanced renal failure. The study will follow the evolution of hormones regulating iron metabolism and put into perspective their links with phosphocalcic and hepatic metabolisms as well as inflammation in hemodialysis patients. The main objective of this program is to study the evolution of hepcidin and erythroferrone levels in hemodialysis patients. These two biomarkers regulating iron metabolism are not performed routinely in dialysis centers and are not listed in the nomenclature.
Eligibility Criteria
Inclusion Criteria: * Adult dialysis patient * Patient able to understand the information necessary for the study and having signed his written consent to participate * Affiliated patient or beneficiary of a social security scheme. Exclusion Criteria: * Medically unstable or frail patient * Patient with hemoglobin less than 7g/dl * Patient with HIV+ or AIDS, patient with replicating hepatitis B or C * Patient participating in another clinical study requiring an additional blood sample * Patient benefiting from legal protection measures (guardianship, guardianship, etc.) adult under guardianship, guardianship or other legal protection, deprived of freedom by judicial or administrative decision * Pregnant, breastfeeding or parturient woman
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05586867 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Iron Metabolism Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05586867 currently recruiting?
Yes, NCT05586867 is actively recruiting participants. Contact the research team at jeanfrancois.oudet@free.fr for enrollment information.
Where is the NCT05586867 trial being conducted?
This trial is being conducted at Quincy-sous-Sénart, France.
Who is sponsoring the NCT05586867 clinical trial?
NCT05586867 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 200 participants.